Exo Therapeutics logo
VerifiedBiotechnology Research· Founded 2018

Exo Therapeutics

Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSightTM platform, Exo is developing a deep pipeline of potent drug candidates that bind exosites, distal and unique binding pockets that have the potential to reprogram enzyme activity for precise and robust therapeutic effect. Through this specific and selective approach to challenging targets, the company’s team of world-class researchers is unlocking breakthrough therapeutics in oncology, inflammation and a broad range of other diseases.

7-day free trial · no credit card

HeadquartersCambridge, United StatesEmployees17(11 to 50)Founded year2018Websiteexo-therapeutics.comLinkedIn profileLinkedIn

Verified contacts

10

available on Kipplo

LinkedIn employees

17

11 to 50 range

Open roles

no listings

Distinct roles

9

indexed titles

Tech stack

1

tools in use

Monthly traffic

organic / mo

Sign up free to see all 10 verified contacts at Exo Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

10 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Exo Therapeutics

9 distinct titles indexed · top 9 shown.

  • 1co-founder & employee 001
  • 1executive assistant to the president
  • 1executive chair
  • 1executive project manager
  • 1principal research associate
  • 1principal scientist protein biochemistry and biophysics
  • 1protein biochemist
  • 1scientist i
  • 1talent advisor

Sign up to unlock all 10 contacts at Exo Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 10 verified contacts at Exo Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.